LifeStance Health Group (NASDAQ:LFST) Coverage Initiated at BMO Capital Markets

Investment analysts at BMO Capital Markets assumed coverage on shares of LifeStance Health Group (NASDAQ:LFST) in a research report issued on Thursday, MarketBeat.com reports. The firm set an “outperform” rating and a $8.00 price target on the stock. BMO Capital Markets’ price objective points to a potential upside of 25.00% from the stock’s previous close.

Several other equities research analysts also recently weighed in on LFST. Wall Street Zen downgraded LifeStance Health Group from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. BTIG Research upped their price target on LifeStance Health Group from $8.00 to $9.00 and gave the company a “buy” rating in a report on Thursday, November 6th. Weiss Ratings restated a “sell (e+)” rating on shares of LifeStance Health Group in a research report on Wednesday, October 8th. Zacks Research lowered shares of LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, November 5th. Finally, UBS Group raised their price target on LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research note on Friday, November 7th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, LifeStance Health Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $9.00.

LifeStance Health Group Stock Up 1.4%

Shares of LifeStance Health Group stock opened at $6.40 on Thursday. The stock has a market cap of $2.49 billion, a price-to-earnings ratio of -213.33 and a beta of 1.15. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.58 and a quick ratio of 1.48. LifeStance Health Group has a 1 year low of $3.74 and a 1 year high of $8.30. The firm’s 50-day moving average is $5.40 and its two-hundred day moving average is $5.27.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.02 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The firm had revenue of $363.81 million for the quarter, compared to analyst estimates of $355.06 million. During the same period in the previous year, the firm earned ($0.02) EPS. LifeStance Health Group’s revenue was up 16.3% on a year-over-year basis. LifeStance Health Group has set its Q4 2025 guidance at EPS. FY 2025 guidance at EPS. As a group, research analysts expect that LifeStance Health Group will post -0.18 earnings per share for the current fiscal year.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, Director Darren M. Black sold 8,407,643 shares of the firm’s stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $42,626,750.01. Following the completion of the transaction, the director directly owned 33,524,715 shares in the company, valued at approximately $169,970,305.05. This trade represents a 20.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, major shareholder Silversmith Partners I. Gp, Llc sold 3,592,357 shares of the stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $5.07, for a total transaction of $18,213,249.99. Following the completion of the sale, the insider owned 14,324,197 shares in the company, valued at $72,623,678.79. This represents a 20.05% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 20,407,643 shares of company stock valued at $103,466,750 in the last quarter. 3.20% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On LifeStance Health Group

A number of institutional investors have recently made changes to their positions in LFST. Jacobs Levy Equity Management Inc. purchased a new position in LifeStance Health Group in the first quarter valued at about $7,932,000. Adage Capital Partners GP L.L.C. raised its holdings in shares of LifeStance Health Group by 43.8% during the 1st quarter. Adage Capital Partners GP L.L.C. now owns 230,000 shares of the company’s stock valued at $1,532,000 after buying an additional 70,000 shares during the period. Victory Capital Management Inc. lifted its position in LifeStance Health Group by 2,599.0% during the 1st quarter. Victory Capital Management Inc. now owns 370,598 shares of the company’s stock worth $2,468,000 after acquiring an additional 356,867 shares in the last quarter. TD Asset Management Inc acquired a new stake in LifeStance Health Group in the second quarter valued at approximately $780,000. Finally, Nuveen LLC purchased a new stake in shares of LifeStance Health Group during the first quarter valued at approximately $6,928,000. 85.50% of the stock is owned by institutional investors and hedge funds.

About LifeStance Health Group

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.